The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Regulatory News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Modern Water plc

14 Sep 2020 10:44

RNS Number : 8860Y
Modern Water PLC
14 September 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Modern Water plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Integumen plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

11 September 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 0.01p each in Integumen plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

 

TOTAL:

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Ordinary shares of 0.01p each in Integumen plc held by the directors of Modern Water plc

 

Name

No. of Integumen plc Shares

% of issued share capital of Integumen plc

Nigel Burton

745,963

0.07

 

 

b) Options over ordinary shares of 0.01p each in Integumen plc held by the directors of Modern Water plc

 

 

Name

No. of Integumen plc Shares

% of issued share capital of Integumen plc

N/A

N/A

N/A

 

c) Rights over ordinary shares of 0.01p each in Integumen plc held by the connected advisers of Modern Water plc

 

Connected Adviser

 

 

 

Number of Integumen plc Shares the subject of Warrants

Exercise Price

Date of Grant

Exercise Period

Percentage of current issued share capital (%)

Turner Pope Investments (TPI) Limited

5,279,999

 

1,800,000

 

300,000

 

8,142,857

1.5p

 

6.25p

 

1.5p

 

1.4p

16/12/19

 

5/4/17

 

5/1/18

 

2/5/19

Until 16/12/22

 

Until 5/4/22

 

Until 5/1/23

 

Until 2/5/22

0.47%

 

0.16%

 

0.03%

 

0.72%

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

14 September 2020

Contact name:

Simon Humphrey (Director)

Telephone number:

+44 (0)20 3827 3439

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEGZGMLLDMGGZG
Date   Source Headline
2nd May 201910:51 amRNSHolding(s) in Company
2nd May 20198:18 amRNSBoard Appointment & Admission of Shares
1st May 201911:00 amRNSChanges to interests of a significant shareholder
30th Apr 20191:18 pmRNSResult of General Meeting
25th Apr 20197:01 amRNSTurner Pope Investor Evening
25th Apr 20197:00 amRNSLaunch of New Animal-Free Labskin Dandruff Test
12th Apr 20197:00 amRNSAcquisition of RinoCloud, Placing to raise £2.518m
25th Mar 20197:00 amRNSCBD tests boost procollagen and reduce irritation
21st Mar 20198:45 amRNSExercise of Warrants - Replacement
21st Mar 20197:01 amRNSExercise of Warrants
21st Mar 20197:00 amRNSLabskin:addl workspace at DHEZ Bradford University
18th Mar 20197:00 amRNSChange of Adviser
13th Mar 20194:35 pmRNSPrice Monitoring Extension
13th Mar 20197:00 amRNSExercise of Options
12th Mar 201910:51 amRNSShare Price Movement
11th Mar 20192:05 pmRNSSecond Price Monitoring Extn
11th Mar 20192:00 pmRNSPrice Monitoring Extension
5th Mar 20194:40 pmRNSSecond Price Monitoring Extn
5th Mar 20194:35 pmRNSPrice Monitoring Extension
5th Mar 20197:01 amRNSIssue of Equity
5th Mar 20197:00 amRNSAcqn of specialist equipment for Labskin's lab
25th Feb 20192:05 pmRNSSecond Price Monitoring Extn
25th Feb 20192:00 pmRNSPrice Monitoring Extension
22nd Feb 20192:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20192:00 pmRNSPrice Monitoring Extension
21st Feb 201911:05 amRNSSecond Price Monitoring Extn
21st Feb 201911:00 amRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSLabskin CBD tests
8th Feb 20197:00 amRNSRollout of Labskin AI Software as a Service begins
7th Feb 20197:00 amRNSChanges to interests of a significant shareholder
23rd Jan 20197:41 amRNSHolding(s) in Company
7th Jan 20197:00 amRNSTrading Update
18th Dec 20187:00 amRNSDivestment of TSPro GmbH
13th Dec 20187:00 amRNSLabskin-On-A-Chip
11th Dec 20181:20 pmRNSIssue of Equity
7th Dec 201812:46 pmRNSResult of Meeting
22nd Nov 20187:00 amRNSSubscription/ Placing to raise £355k, Notice of GM
15th Nov 20182:05 pmRNSSecond Price Monitoring Extn
15th Nov 20182:00 pmRNSPrice Monitoring Extension
15th Nov 20187:00 amRNSTrading Update
1st Nov 20187:00 amRNSCompletion of acq'n of interest in Cellulac plc
11th Oct 20187:00 amRNSUpdate on Placing and Subscription
27th Sep 20183:15 pmRNSUpdate :Placing&Subscription;Trading Announcement
20th Sep 20189:57 amRNSReplacement:legal demand; Placing and Subscription
19th Sep 20187:00 amRNSDetail of legal demand;Placing/Subscription update
17th Sep 20187:00 amRNSFirst laboratory-grown human-skin test service
29th Aug 20187:00 amRNSInterim Results
9th Aug 20184:34 pmRNSResult of AGM
3rd Aug 20183:22 pmRNSShare Purchase Agreement signed; Issue of shares
2nd Aug 20182:57 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.